von Stackelberg O, Kauczor H-U
Diagnostische und Interventionelle Radiologe, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland.
Translationales Lungen Forschungszentrum Heidelberg (TLRC), Mitglied des Deutschen Zentrums für Lungenforschung (DZL), Im Neuenheimer Feld 430, 69120, Heidelberg, Deutschland.
Radiologe. 2016 Sep;56(9):793-7. doi: 10.1007/s00117-016-0141-7.
CLINICAL/METHODICAL ISSUE: Attempts at the early detection of lung cancer using imaging methods began as far back as the 1950s.
Several studies attempted to demonstrate a reduction of lung cancer mortality by chest radiography screening but all were unsuccessful.
Even the first small screening studies using computed tomography (CT) could not demonstrate a reduction in lung cancer-specific mortality until in 2011 the results of the largest randomized controlled low-dose CT screening study in the USA (NLST) were published. The NLST results could show a significant 20 % reduction of lung cancer mortality in elderly and heavy smokers using CT.
Confirmation of the NLST results are urgently needed so that the data of the largest European study (NELSON) are eagerly awaited.
Pooled with the data from several smaller European studies these results will provide important information and evidence for the establishment of future CT screening programs in Europe.
Randomized controlled trials are the basis of evidence-based medicine; therefore, the positive results of the methodologically very good NLST study cannot be ignored, even if it is the only such study completed so far with highly convincing conclusions. The NLST results clearly demonstrate that positive effects for the health of the population can only be expected if the processes are clearly defined and the quality is assured.
临床/方法学问题:早在20世纪50年代就开始尝试使用成像方法早期检测肺癌。
多项研究试图通过胸部X线筛查证明肺癌死亡率降低,但均未成功。
即使是最早使用计算机断层扫描(CT)的小型筛查研究,也未能证明肺癌特异性死亡率降低,直到2011年美国最大的随机对照低剂量CT筛查研究(NLST)结果公布。NLST结果显示,使用CT可使老年重度吸烟者的肺癌死亡率显著降低20%。
迫切需要对NLST结果进行验证,因此人们急切期待欧洲最大规模研究(NELSON)的数据。
将这些结果与欧洲几项较小规模研究的数据汇总,将为欧洲未来CT筛查项目的建立提供重要信息和证据。
随机对照试验是循证医学的基础;因此,方法学上非常出色的NLST研究的阳性结果不容忽视,即便它是目前唯一完成且结论极具说服力的此类研究。NLST结果清楚表明,只有明确界定流程并确保质量,才能预期对人群健康产生积极影响。